glp 1 agonisten Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review The role of GLP1 receptor

[4] Thrombocytopenia and/or leukopenia (rare)

379 Therapeutic modulation of the autophagy-mitophagy axis in NDDs Pharmacological agents Multiple pharmacological agents enhance autophagy through distinct regulatory nodes

When we reduce visceral (active) fat while preserving or building muscle, we: Improve insulin sensitivity Lower inflammatory burden Improve lipid markers Support cognitive protection Lower high blood pressure Reduce long-term disease risk Losing more weight through improved body composition, especially by targeting active fat, can have greater long-term health benefits, including better maintenance of weight loss and reduced risk of conditions like diabetes and heart disease

Abbreviations: M3, muscarinic acetylcholine receptor subtype 3